Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-09-13
1994-12-20
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 514 16, 514 17, A61K 3702
Patent
active
053746210
ABSTRACT:
A method of retarding vascular leakage caused by tissue injury comprises administering a neurotensin or a neurotensin analog (SEQ ID NO: 1) at dosages sufficient to prevent or retard injury induced vascular leakage following injury or before deliberate injury.
REFERENCES:
patent: 3926756 (1975-12-01), Leeman
patent: 3928306 (1975-12-01), Uchiyama
patent: 4091090 (1978-05-01), Sipos
patent: 4110321 (1978-08-01), Folkers
patent: 4425269 (1984-01-01), Christy et al.
patent: 4439359 (1984-03-01), Holly, deceased et al.
patent: 4665157 (1987-05-01), Wright
patent: 4716149 (1987-12-01), Bonelli et al.
patent: 4732890 (1988-03-01), Bonelli et al.
patent: 4801612 (1989-01-01), Wei
Carraway et al., "Neurotensin and Related Peptides", Chpt. 4, The Comparative Physiology of Regulatory Peptides, ed. Holmgren, London: Chapmann & Hall, (1989).
Foreman et al., "Interaction of Neurotension with the Substance P Receptor Mediating Histamine Release from Rat Mast Cells and the Flare in Human Skin", Br. J. Pharmac., 77, 531-539 (1982).
Araki et al., "Isolation and Structure of a New Active Peptide `Xenopsin` on the Smooth Muscle, Especially on a Strip of Fundus from a Rat Stomach, from the Skin of Xenopus iaevis," Chem. Pharm. Bull., 21 (12), 2801-2804 (1973).
Di Paola et al., "Cardiovascular Effects of Neurotension and Some Analogues on Rats", European Journal of Pharmacology, 175, 279-283 (1990).
Rivier et al., "Neurotension Analogues. Structure-Activity Relationships", Journal of Medicinal Chemistry, 20 (11), 1409-1412 (1977).
Granier et al., "Synthesis and Characterization of Neurotensin Analogues for Structure/Activity Relationship Studies".
Lee L.
Regents of the University of California
Schain Howard E.
LandOfFree
Neurotensin method for inhibiting vascular leakage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neurotensin method for inhibiting vascular leakage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurotensin method for inhibiting vascular leakage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2386275